Clinical Trials Logo

Clinical Trial Summary

The pandemic of coronavirus disease 2019 (COVID-19) has serious implications on urology practice and raises particular questions for urologists about the management of different conditions. It was recommended to cancel most of the elective urological surgeries. (1) The least invasive intervention modalities that can be completed in local or regional anesthesia will serve the best interest of patients and urologists. 10 14 Endoscopic surgery is considered relatively safe.(2) After end of pandemic we facing complication of this era, one of most common complication was JJ stents complications as most of patient and doctors prefers to defer most of elective management by just JJ insertion and postpone definitive treatment. (3) In this study we discuss retrospectively the complication of JJ stenting during Covid 19 pandemic.


Clinical Trial Description

Type of the study: retrospective clinical study - Study Setting: Qena University Hospital 3- Study subjects: a. Inclusion criteria: all patients performing JJ stent placement during Covid 19 pandemics b. Exclusion criteria: Patients refuse to participate in this study c. Sample Size Calculation: all patients performing JJ stent placement from March 2020 to December 2021 - Study tools (in detail, e.g., lab methods, instruments, steps, chemicals, …): - Medical history - Complete physical examination. - All patents presented was investigated by 1. Abdominal U.S 2. Plain X Ray 3. Non contrast CT 4. Serum Creatinine 5. Urine Analysis - Research outcome measures: 1. Primary (main): determine effect of urological malpractice during Covid 19 on patient complications 2. Secondary (subsidiary): determine JJ stent complications during Covid 19 pandemics ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05839249
Study type Observational
Source South Valley University
Contact
Status Active, not recruiting
Phase
Start date January 1, 2020
Completion date May 15, 2023